0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Eluting Balloon for Peripheral Artery Disease Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-18I7513
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Drug Eluting Balloon for Peripheral Artery Disease Market Insights and Forecast to 2028
BUY CHAPTERS

Global Drug Eluting Balloon for Peripheral Artery Disease Market Research Report 2025

Code: QYRE-Auto-18I7513
Report
August 2025
Pages:71
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Drug Eluting Balloon for Peripheral Artery Disease Market Size

The global market for Drug Eluting Balloon for Peripheral Artery Disease was valued at US$ 344 million in the year 2024 and is projected to reach a revised size of US$ 482 million by 2031, growing at a CAGR of 5.0% during the forecast period.

Drug Eluting Balloon for Peripheral Artery Disease Market

Drug Eluting Balloon for Peripheral Artery Disease Market

A drug eluting balloon is a semi-compliant angioplasty balloon that is surrounded by an anti-proliferative medicine. The medicine is ejected to the vessel wall during the inflation of the balloon. The active substance of the balloon is highly lipophilic (dissolved in lipids or fats). The drug eluting balloon homogeneously delivers the drug to the vessel and provides treatment for peripheral artery disease.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drug Eluting Balloon for Peripheral Artery Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Balloon for Peripheral Artery Disease.
The Drug Eluting Balloon for Peripheral Artery Disease market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Eluting Balloon for Peripheral Artery Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Eluting Balloon for Peripheral Artery Disease manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Drug Eluting Balloon for Peripheral Artery Disease Market Report

Report Metric Details
Report Name Drug Eluting Balloon for Peripheral Artery Disease Market
Accounted market size in year US$ 344 million
Forecasted market size in 2031 US$ 482 million
CAGR 5.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 3μg/ mm2
  • 2μg/ mm2
  • Others
Segment by Application
  • Hospitals
  • Ambulatory Surgery Centers
  • Catheterization Laboratories
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Cook Group, BD, Medtronic, Bayer, Opto Circuits
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Drug Eluting Balloon for Peripheral Artery Disease manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Drug Eluting Balloon for Peripheral Artery Disease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Drug Eluting Balloon for Peripheral Artery Disease Market growing?

Ans: The Drug Eluting Balloon for Peripheral Artery Disease Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the Drug Eluting Balloon for Peripheral Artery Disease Market size in 2031?

Ans: The Drug Eluting Balloon for Peripheral Artery Disease Market size in 2031 will be US$ 482 million.

Who are the main players in the Drug Eluting Balloon for Peripheral Artery Disease Market report?

Ans: The main players in the Drug Eluting Balloon for Peripheral Artery Disease Market are Cook Group, BD, Medtronic, Bayer, Opto Circuits

What are the Application segmentation covered in the Drug Eluting Balloon for Peripheral Artery Disease Market report?

Ans: The Applications covered in the Drug Eluting Balloon for Peripheral Artery Disease Market report are Hospitals, Ambulatory Surgery Centers, Catheterization Laboratories, Others

What are the Type segmentation covered in the Drug Eluting Balloon for Peripheral Artery Disease Market report?

Ans: The Types covered in the Drug Eluting Balloon for Peripheral Artery Disease Market report are 3μg/ mm2, 2μg/ mm2, Others

1 Drug Eluting Balloon for Peripheral Artery Disease Market Overview
1.1 Product Definition
1.2 Drug Eluting Balloon for Peripheral Artery Disease by Type
1.2.1 Global Drug Eluting Balloon for Peripheral Artery Disease Market Value Comparison by Type (2024 VS 2031)
1.2.2 3μg/ mm2
1.2.3 2μg/ mm2
1.2.4 Others
1.3 Drug Eluting Balloon for Peripheral Artery Disease by Application
1.3.1 Global Drug Eluting Balloon for Peripheral Artery Disease Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Ambulatory Surgery Centers
1.3.4 Catheterization Laboratories
1.3.5 Others
1.4 Global Drug Eluting Balloon for Peripheral Artery Disease Market Size Estimates and Forecasts
1.4.1 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue 2020-2031
1.4.2 Global Drug Eluting Balloon for Peripheral Artery Disease Sales 2020-2031
1.4.3 Global Drug Eluting Balloon for Peripheral Artery Disease Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Drug Eluting Balloon for Peripheral Artery Disease Market Competition by Manufacturers
2.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Manufacturers (2020-2025)
2.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Drug Eluting Balloon for Peripheral Artery Disease Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Drug Eluting Balloon for Peripheral Artery Disease, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug Eluting Balloon for Peripheral Artery Disease, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug Eluting Balloon for Peripheral Artery Disease, Product Type & Application
2.7 Global Key Manufacturers of Drug Eluting Balloon for Peripheral Artery Disease, Date of Enter into This Industry
2.8 Global Drug Eluting Balloon for Peripheral Artery Disease Market Competitive Situation and Trends
2.8.1 Global Drug Eluting Balloon for Peripheral Artery Disease Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Drug Eluting Balloon for Peripheral Artery Disease Players Market Share by Revenue
2.8.3 Global Drug Eluting Balloon for Peripheral Artery Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drug Eluting Balloon for Peripheral Artery Disease Market Scenario by Region
3.1 Global Drug Eluting Balloon for Peripheral Artery Disease Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Region: 2020-2031
3.2.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Region: 2020-2025
3.2.2 Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Region: 2026-2031
3.3 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region: 2020-2031
3.3.1 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region: 2020-2025
3.3.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region: 2026-2031
3.4 North America Drug Eluting Balloon for Peripheral Artery Disease Market Facts & Figures by Country
3.4.1 North America Drug Eluting Balloon for Peripheral Artery Disease Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2020-2031)
3.4.3 North America Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Drug Eluting Balloon for Peripheral Artery Disease Market Facts & Figures by Country
3.5.1 Europe Drug Eluting Balloon for Peripheral Artery Disease Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2020-2031)
3.5.3 Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Market Facts & Figures by Region
3.6.1 Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Sales by Region (2020-2031)
3.6.3 Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Drug Eluting Balloon for Peripheral Artery Disease Market Facts & Figures by Country
3.7.1 Latin America Drug Eluting Balloon for Peripheral Artery Disease Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2020-2031)
3.7.3 Latin America Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2020-2031)
3.8.3 Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2020-2031)
4.1.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2020-2025)
4.1.2 Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2026-2031)
4.1.3 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2020-2031)
4.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Type (2020-2031)
4.2.1 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Type (2020-2025)
4.2.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Type (2026-2031)
4.2.3 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Type (2020-2031)
4.3 Global Drug Eluting Balloon for Peripheral Artery Disease Price by Type (2020-2031)
5 Segment by Application
5.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2020-2031)
5.1.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2020-2025)
5.1.2 Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2026-2031)
5.1.3 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2020-2031)
5.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Application (2020-2031)
5.2.1 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Application (2020-2025)
5.2.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Application (2026-2031)
5.2.3 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Application (2020-2031)
5.3 Global Drug Eluting Balloon for Peripheral Artery Disease Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Cook Group
6.1.1 Cook Group Company Information
6.1.2 Cook Group Description and Business Overview
6.1.3 Cook Group Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Cook Group Drug Eluting Balloon for Peripheral Artery Disease Product Portfolio
6.1.5 Cook Group Recent Developments/Updates
6.2 BD
6.2.1 BD Company Information
6.2.2 BD Description and Business Overview
6.2.3 BD Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BD Drug Eluting Balloon for Peripheral Artery Disease Product Portfolio
6.2.5 BD Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Company Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Medtronic Drug Eluting Balloon for Peripheral Artery Disease Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Company Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bayer Drug Eluting Balloon for Peripheral Artery Disease Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 Opto Circuits
6.5.1 Opto Circuits Company Information
6.5.2 Opto Circuits Description and Business Overview
6.5.3 Opto Circuits Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Opto Circuits Drug Eluting Balloon for Peripheral Artery Disease Product Portfolio
6.5.5 Opto Circuits Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Eluting Balloon for Peripheral Artery Disease Industry Chain Analysis
7.2 Drug Eluting Balloon for Peripheral Artery Disease Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Eluting Balloon for Peripheral Artery Disease Production Mode & Process Analysis
7.4 Drug Eluting Balloon for Peripheral Artery Disease Sales and Marketing
7.4.1 Drug Eluting Balloon for Peripheral Artery Disease Sales Channels
7.4.2 Drug Eluting Balloon for Peripheral Artery Disease Distributors
7.5 Drug Eluting Balloon for Peripheral Artery Disease Customer Analysis
8 Drug Eluting Balloon for Peripheral Artery Disease Market Dynamics
8.1 Drug Eluting Balloon for Peripheral Artery Disease Industry Trends
8.2 Drug Eluting Balloon for Peripheral Artery Disease Market Drivers
8.3 Drug Eluting Balloon for Peripheral Artery Disease Market Challenges
8.4 Drug Eluting Balloon for Peripheral Artery Disease Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Drug Eluting Balloon for Peripheral Artery Disease Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Drug Eluting Balloon for Peripheral Artery Disease Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Drug Eluting Balloon for Peripheral Artery Disease Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Drug Eluting Balloon for Peripheral Artery Disease Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Drug Eluting Balloon for Peripheral Artery Disease, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Drug Eluting Balloon for Peripheral Artery Disease, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Drug Eluting Balloon for Peripheral Artery Disease, Product Type & Application
 Table 12. Global Key Manufacturers of Drug Eluting Balloon for Peripheral Artery Disease, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Drug Eluting Balloon for Peripheral Artery Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Balloon for Peripheral Artery Disease as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Drug Eluting Balloon for Peripheral Artery Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Region (2020-2025) & (K Units)
 Table 18. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Region (2020-2025)
 Table 19. Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Region (2026-2031) & (K Units)
 Table 20. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Region (2026-2031)
 Table 21. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Region (2020-2025)
 Table 23. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Region (2026-2031)
 Table 25. North America Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2020-2025) & (K Units)
 Table 27. North America Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2026-2031) & (K Units)
 Table 28. North America Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Type (2020-2025)
 Table 51. Global Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Type (2026-2031)
 Table 52. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2020-2025)
 Table 53. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2026-2031)
 Table 54. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Type (2020-2025)
 Table 57. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Type (2026-2031)
 Table 58. Global Drug Eluting Balloon for Peripheral Artery Disease Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Drug Eluting Balloon for Peripheral Artery Disease Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Application (2020-2025)
 Table 61. Global Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Application (2026-2031)
 Table 62. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2020-2025)
 Table 63. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2026-2031)
 Table 64. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Application (2020-2025)
 Table 67. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Application (2026-2031)
 Table 68. Global Drug Eluting Balloon for Peripheral Artery Disease Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Drug Eluting Balloon for Peripheral Artery Disease Price (USD/Unit) by Application (2026-2031)
 Table 70. Cook Group Company Information
 Table 71. Cook Group Description and Business Overview
 Table 72. Cook Group Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Cook Group Drug Eluting Balloon for Peripheral Artery Disease Product
 Table 74. Cook Group Recent Developments/Updates
 Table 75. BD Company Information
 Table 76. BD Description and Business Overview
 Table 77. BD Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. BD Drug Eluting Balloon for Peripheral Artery Disease Product
 Table 79. BD Recent Developments/Updates
 Table 80. Medtronic Company Information
 Table 81. Medtronic Description and Business Overview
 Table 82. Medtronic Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Medtronic Drug Eluting Balloon for Peripheral Artery Disease Product
 Table 84. Medtronic Recent Developments/Updates
 Table 85. Bayer Company Information
 Table 86. Bayer Description and Business Overview
 Table 87. Bayer Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Bayer Drug Eluting Balloon for Peripheral Artery Disease Product
 Table 89. Bayer Recent Developments/Updates
 Table 90. Opto Circuits Company Information
 Table 91. Opto Circuits Description and Business Overview
 Table 92. Opto Circuits Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Opto Circuits Drug Eluting Balloon for Peripheral Artery Disease Product
 Table 94. Opto Circuits Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Drug Eluting Balloon for Peripheral Artery Disease Distributors List
 Table 98. Drug Eluting Balloon for Peripheral Artery Disease Customers List
 Table 99. Drug Eluting Balloon for Peripheral Artery Disease Market Trends
 Table 100. Drug Eluting Balloon for Peripheral Artery Disease Market Drivers
 Table 101. Drug Eluting Balloon for Peripheral Artery Disease Market Challenges
 Table 102. Drug Eluting Balloon for Peripheral Artery Disease Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Drug Eluting Balloon for Peripheral Artery Disease
 Figure 2. Global Drug Eluting Balloon for Peripheral Artery Disease Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Drug Eluting Balloon for Peripheral Artery Disease Market Share by Type: 2024 & 2031
 Figure 4. 3μg/ mm2 Product Picture
 Figure 5. 2μg/ mm2 Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Drug Eluting Balloon for Peripheral Artery Disease Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Drug Eluting Balloon for Peripheral Artery Disease Market Share by Application: 2024 & 2031
 Figure 9. Hospitals
 Figure 10. Ambulatory Surgery Centers
 Figure 11. Catheterization Laboratories
 Figure 12. Others
 Figure 13. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Drug Eluting Balloon for Peripheral Artery Disease Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Drug Eluting Balloon for Peripheral Artery Disease Sales (2020-2031) & (K Units)
 Figure 16. Global Drug Eluting Balloon for Peripheral Artery Disease Average Price (USD/Unit) & (2020-2031)
 Figure 17. Drug Eluting Balloon for Peripheral Artery Disease Report Years Considered
 Figure 18. Drug Eluting Balloon for Peripheral Artery Disease Sales Share by Manufacturers in 2024
 Figure 19. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Drug Eluting Balloon for Peripheral Artery Disease Players: Market Share by Revenue in Drug Eluting Balloon for Peripheral Artery Disease in 2024
 Figure 21. Drug Eluting Balloon for Peripheral Artery Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Drug Eluting Balloon for Peripheral Artery Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country (2020-2031)
 Figure 24. North America Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country (2020-2031)
 Figure 28. Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Region (2020-2031)
 Figure 36. China Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Drug Eluting Balloon for Peripheral Artery Disease by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Drug Eluting Balloon for Peripheral Artery Disease by Type (2020-2031)
 Figure 58. Global Drug Eluting Balloon for Peripheral Artery Disease Price (USD/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Drug Eluting Balloon for Peripheral Artery Disease by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Drug Eluting Balloon for Peripheral Artery Disease by Application (2020-2031)
 Figure 61. Global Drug Eluting Balloon for Peripheral Artery Disease Price (USD/Unit) by Application (2020-2031)
 Figure 62. Drug Eluting Balloon for Peripheral Artery Disease Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart